Table 2.
Treatment | Days | ||||
---|---|---|---|---|---|
3 | 4 | 5 | 6 | 7 | |
Control | + | + | + | + | + |
E-282 | − | − | + | + | + |
8 mg/g | − | + | + | + | + |
16 mg/g | − | − | + | + | + |
33 mg/g | − | − | − | + | + |
50 mg/g | − | − | − | − | − |
(+) Positive growth; (−) Negative growth.
Treatment | Days | ||||
---|---|---|---|---|---|
3 | 4 | 5 | 6 | 7 | |
Control | + | + | + | + | + |
E-282 | − | − | + | + | + |
8 mg/g | − | + | + | + | + |
16 mg/g | − | − | + | + | + |
33 mg/g | − | − | − | + | + |
50 mg/g | − | − | − | − | − |
(+) Positive growth; (−) Negative growth.